DV-1179

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDV-1179
Drug Alias NameDV-1179DV-1079
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionToll like receptor 7 antagonistsToll like receptor 9 antagonists
TargetsToll like receptor 9Toll like receptor 7
Therapy Area/IndicationsLupus Erythematosus, Systemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDynavax Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDynavax Gmbh
Active IndicationsN/A
Inactive IndicationsLupus Erythematosus, Systemic

Other Information

ATC CodeN/A
Related LinksN/A